Genprex, Inc. | License Agreements | Business Contracts

Exclusive License Agreement, dated December 29, 2022 (Filed With SEC on January 5, 2023)

Exclusive License Agreement, dated November 22, 2022 (Filed With SEC on November 28, 2022)

First Amendment to Exclusive License Agreement, dated August 17, 2022 (Filed With SEC on August 22, 2022)

Amendment No. 1 to Patent and Technology License Agreement, dated March 3, 2021, by and between the Registrant and The University of Texas M.D. Anderson Cancer Center (Filed With SEC on March 26, 2021)

Patent and Technology License Agreement dated as of May 4, 2020, by and between Genprex, Inc. and The Board of Regents of The University of Texas System (Filed With SEC on May 14, 2020)

EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on February 18, 2020)

Genprex, Inc. (43) | License Agreements (6)